Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4–6 inhibitors

mCXI is associated with overall survival in metastatic breast cancer patients who are treated with CDK 4-6 inhibitors.

Authors

Taha Koray Şahin (ORCID: https://orcid.org/0000-0002-3590-0426)
Mert Tokatlı (ORCID: https://orcid.org/0000-0003-4914-7903)
Sercan Aksoy (ORCID: https://orcid.org/0000-0003-4984-1049)
Onur Baş (ORCID: https://orcid.org/0000-0002-8726-0360)
Çetin Kılınç (ORCID: https://orcid.org/0000-0003-4958-2622)
Latif Karahan (ORCID: https://orcid.org/0000-0001-5238-0883)
Naciye Güdük
Yiğit Yazarkan (ORCID: https://orcid.org/0009-0000-8989-5207)
Deniz Can Güven (ORCID: https://orcid.org/0000-0002-6924-9467)
Mehmet Şavklıyıldız